Anti-thrombogenic medical devices and methods
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61F-002/82
A61L-031/00
A61L-031/02
A61L-031/10
A61L-031/16
A61F-002/90
A61F-002/06
A61L-031/14
A61L-033/00
A61L-033/06
B05D-001/18
B05D-003/14
출원번호
US-0584077
(2017-05-02)
등록번호
US-10137012
(2018-11-27)
발명자
/ 주소
Ma, Xiaodong
Sheu, Min-Shyan
Eramo, Lincoln
Wainwright, Jr., John
Li, Junwei
출원인 / 주소
COVIDIEN LP
대리인 / 주소
Shumaker & Sieffert, P.A.
인용정보
피인용 횟수 :
0인용 특허 :
123
초록▼
Methods for forming an expandable tubular body having a plurality of braided filaments including a first filament including platinum or platinum alloy and a second filament including cobalt-chromium alloy. The methods include applying a first phosphorylcholine material directly on the platinum or pl
Methods for forming an expandable tubular body having a plurality of braided filaments including a first filament including platinum or platinum alloy and a second filament including cobalt-chromium alloy. The methods include applying a first phosphorylcholine material directly on the platinum or platinum alloy of the first filament and applying a silane material on the second filament followed by a second phosphorylcholine material on the silane material on the second filament. The first and second phosphorylcholine materials each define a thickness of less than 100 nanometers.
대표청구항▼
1. A method comprising: forming an expandable tubular body comprising a plurality of braided filaments, wherein the expandable tubular body is configured to be implanted in a blood vessel, the plurality of braided filaments comprising a first filament comprising platinum or platinum alloy and a seco
1. A method comprising: forming an expandable tubular body comprising a plurality of braided filaments, wherein the expandable tubular body is configured to be implanted in a blood vessel, the plurality of braided filaments comprising a first filament comprising platinum or platinum alloy and a second filament comprising cobalt-chromium alloy;applying a first phosphorylcholine material directly on the platinum or platinum alloy of the first filament;applying a silane material to the second filament comprising the cobalt-chromium alloy, wherein the silane material comprises a silane selected from the group consisting of 3-glycidoxypropyltrimethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltriethoxysilane, 2-(3,4-epoxycyclohexyl)ethyl-trimethoxysilane, (3-glycidoxypropyl)trimethoxysilane, (3-glycidoxypropyl)triethoxysilane, 5,6-epoxyhexyltriethoxysilane, (3-glycidoxypropyl)methyldiethoxysilane, (3-glycidoxypropyl)methyldimethoxysilane, (3-glycidoxypropyl)dimethylethoxysilane, 3-isocyanatopropyltriethoxysilane, (isocyanatomethyl)methyldimethoxysilane, 3-isocyanatopropyltrimethoxysilane, tris(3-trimethoxysilylpropyl)isocyanurate, (3-triethoxysilylpropyl)-t-butylcarbamate, triethoxysilylpropylethylcarbamate, 3-thiocyanatopropyltriethoxysilane, and combinations thereof; andapplying a second phosphorylcholine material on the silane material on the second filament,wherein the first and second phosphorylcholine materials each define a thickness of less than 100 nanometers. 2. The method of claim 1, wherein the first and second phosphorylcholine materials are selected from the group consisting of 2-methacryloyloxyethyl phosphorylcholine, 2-acryloyloxyethyl phosphorylcholine, and phosphorylcholines based upon monomers including 2-(meth)acryloyloxyethyl-2′-(trimethylammonio)ethyl phosphate, 3-(meth)acryloyloxypropyl-2′-(trimethylammonio)ethyl phosphate, 4-(meth)acryloyloxybutyl-2′-(trimethylammonio)ethyl phosphate, 5-(meth)acryloyloxypentyl-2′-(trimethylammonio)ethyl phosphate, 6-(meth)acryloyloxyhexyl-2′-(trimethylammonio)ethyl phosphate, 2-(meth)acryloyloxyethyl-2′-(triethylammonio)ethyl phosphate, 2-(meth)acryloyloxyethyl-2′-(tripropylammonio) ethyl phosphate, 2-(meth)acryloyloxyethyl-2′-(tributylammonio)ethyl phosphate, 2-(meth)acryloyloxypropyl-2′-(trimethylammonio)ethyl phosphate, 2-(meth)acryloyloxybutyl-2′-(trimethylammonio)ethyl phosphate, 2-(meth)acryloyloxypentyl-2′-(trimethylammonio)ethyl phosphate, 2-(meth)acryloyloxyhexyl-2′-(trimethylammonio)ethyl phosphate, 2-(meth)acryloyloxyethyl-3′-(trimethylammonio)propyl phosphate, 3-(meth)acryloyloxypropyl-3′-(trimethylammonio)propyl phosphate, 4-(meth)acryloyloxybutyl-3′-(trimethylammonio)propyl phosphate, 5-(meth)acryloyloxypentyl-3′-(trimethylammonio)propyl phosphate, 6-(meth)acryloyloxyhexyl-3′-(trimethylammonio)propyl phosphate, 2-(meth)acryloyloxyethyl-4′-(trimethylammonio)butyl phosphate, 3-(meth)acryloyloxypropyl-4′-(trimethylammonio)butyl phosphate, 4-(meth)acryloyloxybutyl-4′-(trimethylammonio)butyl phosphate, 5-(meth)acryloyloxypentyl-4′-(trimethylammonio)butyl phosphate, 6-(meth)acryloyloxyhexyl-4′-(trimethylammonio)butylphosphate, and combinations thereof. 3. The method of claim 1, wherein the first and second phosphorylcholine materials each comprise a copolymer having a reactive chemical group selected from the group consisting of amine, hydroxyl, epoxy, silane, aldehyde, carboxylate and thiol. 4. The method of claim 1, wherein the first phosphorylcholine material, or a polymer or copolymer thereof, is chemically bonded directly to the first filament. 5. The method of claim 1, wherein the first phosphorylcholine material, or a polymer or copolymer thereof, is covalently bonded to the first filament. 6. The method of claim 1, wherein the second phosphorylcholine material, or a polymer or copolymer thereof, is covalently bonded to the silane material on the second filament. 7. The method of claim 1, wherein the silane material comprises 3-glycidoxypropyltrimethoxysilane. 8. The method of claim 1, wherein forming the expandable tubular body comprises braiding the plurality of braided filaments to form a sidewall having a plurality of pores therein, the plurality of pores being sized to inhibit flow of blood through the sidewall into an aneurysm to a degree sufficient to lead to thrombosis and healing of the aneurysm when the expandable tubular body is positioned in a blood vessel and adjacent to the aneurysm. 9. The method of claim 1, wherein forming the expandable tubular body comprises braiding the plurality of braided filaments to form a sidewall having a plurality of pores therein, the plurality of pores having an average pore size that is less than or equal to 500 microns. 10. The method of claim 1, further comprising heat setting the expandable tubular body prior to applying the first or second phosphorylcholine materials. 11. The method of claim 10, wherein heat setting the expandable tubular body comprises positioning the expandable tubular body in an expanded state during the heat setting. 12. The method of claim 1, wherein the first and second phosphorylcholine materials form an outermost surface of the respective first and second filaments. 13. The method of claim 1, further comprising, prior to applying the silane material or the first phosphorylcholine material, hydroxylating at least some braided filaments of the plurality of braided filaments. 14. The method of claim 1, wherein the expandable tubular body with the first and second phosphorylcholine material applied to the first and second filaments exhibits an elapsed time before peak thrombin formation that is at least 1.5 times the elapsed time before peak thrombin formation for an identical device whose braided filaments are entirely bare metal. 15. The method of claim 1, wherein the expandable tubular body with the first and second phosphorylcholine material applied to the first and second filaments exhibits a peak thrombin concentration that is less than 0.8 times the peak thrombin concentration for an identical device whose braided filaments are entirely bare metal. 16. The method of claim 1, wherein the first and second phosphorylcholine materials each define a thickness from about 1 nanometer to about 25 nanometers. 17. The method of claim 1, wherein the first and second phosphorylcholine materials each define a thickness from about 1 nanometer to about 10 nanometers. 18. The method of claim 1, wherein the expandable tubular body comprises a self-expanding stent. 19. The method of claim 1, further comprising deploying the expandable tubular body into a blood vessel of a patient so that a sidewall of the expandable tubular body extends across a neck of an aneurysm, thereby causing thrombosis within the aneurysm. 20. The method of claim 1, wherein the first and second phosphorylcholine materials comprise 2-methacryloyloxyethyl phosphorylcholine (MPC).
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (123)
Morris, Grayson; Atladottir, Svava Maria; Pienknagura, Carla, Abluminal stent coating apparatus and method using a brush assembly.
Solomon Donald D. (Spring Valley OH) Byron M. Parke (Centerville OH), Anti-infective and antithrombogenic medical articles and method for their preparation.
Fearnot Neal E. (West Lafayette IN) Kozma Thomas G. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees William D. (West Lafayette IN), Coated implantable medical device.
Wainwright, John; Mendelson, Todd; Haggstrom, Kurt; Molaei, Masoud; Schuman, Victoria; Sheu, Min-Shyan, Coated medical devices and methods of making and using same.
Wainwright, John; Mendelson, Todd; Haggstrom, Kurt; Molaei, Masoud; Schuman, Victoria; Sheu, Min-Shyan, Coated medical devices and methods of making and using same.
Leon V. Rudakov ; Mir A. Imran ; Linh Dinh ; Ara Davidian ; Kevin T. Larkin, Composite expandable device with impervious polymeric covering and bioactive coating thereon, delivery apparatus and method.
Pham Pete P. (Fremont CA) Doan Hong (Santa Clara CA) Sepetka Ivan (Los Altos CA) Eder Joseph (Los Altos CA) Snyder Edward (San Jose CA), Electrolytically severable joint for endovascular embolic devices.
Alt Eckhard,DEX ; Fliedner Thilo,DEX ; Alter Robert,DEX ; Stemberger Axel,DEX, Implantable vascular and endoluminal stents and process of fabricating the same.
Fox ; Jr. Charles L. (New York NY) Modak Shanta M. (River Edge NJ) Sampath Lester A. (Nyack NY), Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same.
Fox ; Jr. Charles L. (New York NY) Modak Shanta M. (River Edge NJ) Sampath Lester A. (Nyack NY), Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same.
Fischell Robert E. (14600 Viburnum Dr. Dayton MD 21036) Fischell David R. (71 Riverlawn Dr. Fair Haven NJ 07704) Fischell Tim A. (1018 Chancery Dr. Nashville TN 37215), Multi-cell stent with cells having differing characteristics.
Hoffman Allan S. (King County WA) Garfinkle Andrew (King County WA) Ratner Buddy D. (King County WA) Hanson Stephen R. (San Diego County CA), Plasma gas discharge treatment for improving the biocompatibility of biomaterials.
Berry Dale T. ; Herald Coy M. ; Bates Brian L. ; Boatman Scott E. ; Hoffa Michael C. ; Fearnot Neal E. ; Voorhees ; III William D., Radially expandable stent.
Narayanan Pallassana V. (Davie FL) Stanley Kimberly D. (Florida City FL), Radiofrequency plasma treated polymeric surfaces having immobilized anti-thrombogenic agents.
Narayanan Pallassana V. (Davie FL) Stanley Kimberly D. (Florida City FL), Radiofrequency plasma treated polymeric surfaces having immobilized anti-thrombogenic agents.
Yamaya Masaaki,JPX ; Kizaki Hiroaki,JPX ; Furuya Masahiro,JPX ; Yamamoto Akira,JPX, Silicone resin-containing emulsion composition, method for making same, and article having a cured film of same.
Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Osborne Thomas A. ; Kozma Thomas G. ; Roberts Joseph W. ; Voorhees ; III William D., Silver implantable medical device.
Dusbabek Andrew J. ; Ellis Louis G. ; Larson Christopher R. ; Brown Terry V. ; Euteneuer Charles L. ; Mertens Steven P. ; Mattison Richard C. ; Blaeser David J. ; Lorentzen Cornelius Linda R. ; Willa, Stent delivery system having stent securement apparatus.
Dusbabek, Andrew J.; Ellis, Louis G.; Larson, Christopher R.; Brown, Terry V.; Euteneuer, Charles L.; Mertens, Steven P.; Mattison, Richard C.; Blaeser, David J.; Lorentzen Cornelius, Linda R.; Willa, Stent delivery system having stent securement apparatus.
DeLaurentis Mark (Ocean Springs MS) Pourrezaei Kambiz (Dresher PA) Boxman Raymond L. (Herzliya NJ ILX) Beard Richard B. (Atco NJ), Urinary catheter and system.
Patnaik Birendra K. ; Lin Horng-Ban ; Lentz David J. ; Zdrahala Richard J., ePTFE small caliber vascular grafts with significant patency enhancement via a surface coating which contains covalently bonded heparin.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.